Form 4: AnaptysBio Director Hollings Renton Executes Stock Option and Sells Shares
SEC Form 4
Director Hollings Renton exercised stock options and sold shares of AnaptysBio, Inc. on July 15, 2024, according to a Form 4 filing.
Summary
- On July 15, 2024, Hollings Renton, a director of AnaptysBio, Inc., exercised stock options to acquire 10,000 shares of common stock at a price of $6.93 per share.
- Renton also sold 7,103 shares at a weighted average price of $30.5038, with prices ranging from $29.91 to $30.88 per share.
- Additionally, Renton sold 2,897 shares at a weighted average price of $30.9817, with prices ranging from $30.92 to $31.27 per share.
- Following these transactions, Renton directly owns 1,950 shares of AnaptysBio common stock.
- The sale was executed under a Rule 10b5-1 trading plan adopted on March 14, 2024, to facilitate the orderly exercise of stock options expiring in 2025.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports insider trading activity. The director is exercising options and selling shares, which could be for various personal financial reasons and doesn't necessarily reflect a positive or negative view of the company.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common in the biopharmaceutical industry. Monitoring such filings can provide insights into management's perspective on the company's stock and future prospects.
Stakeholder Impact
- Shareholders may be interested in insider trading activity as it can provide insights into management's views on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 03/14/2024 | Rule 10b5-1 trading plan adopted by the Reporting Person |
| 07/15/2024 | Date of transaction: exercise of stock options and sale of shares |
| 07/05/2025 | Expiration date of the stock option grant |
| 07/17/2024 | Date of signature of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.